Chen Han, Chen Enguang, Liu Miaomiao, Wang Jianhui, Yin Jiawei, Zhao Peiquan, Xu Yu
Department of Ophthalmology, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Front Endocrinol (Lausanne). 2024 Aug 30;15:1341206. doi: 10.3389/fendo.2024.1341206. eCollection 2024.
Proliferative diabetic retinopathy (PDR) is a severe complication of diabetes, and understanding its molecular mechanisms is crucial. Endoplasmic reticulum (ER) stress has been implicated in various diseases, including diabetic complications. This study aims to elucidate ER stress-related biomarkers in PDR, providing insights into the underlying molecular pathways.
We analyzed two independent PDR datasets, GSE102485 and GSE60436. The GSE102485 dataset (22 PDR and 3 normal samples) was the primary dataset for comprehensive analyses, including differential expression, functional enrichment, PPI network construction, immune cell infiltration, and drug prediction. The GSE60436 dataset (6 PDR and 3 normal samples) was used for validation. experiments using human umbilical vein endothelial cells (HUVECs) in a high-glucose environment were conducted to validate key bioinformatics outcomes. Western blotting assessed protein levels of ER stress markers (TRAM1 and TXNIP).
Differential expression analysis identified 2451 genes, including 328 ER stress-related genes. Functional analysis revealed enrichment in ER stress-related processes and pathways. Hub genes (BCL2, CCL2, IL-1β, TLR4, TNF, TP53) were identified, and immune infiltration analysis showed altered immune cell proportions. Validation in GSE60436 and confirmed ER stress gene dysregulation. Drug prediction suggested potential small molecules targeting ER stress markers.
This study provides a comprehensive molecular characterization of ER stress in PDR, highlighting altered biological processes, immune changes, and potential therapeutic targets. The identified hub genes and small molecules offer avenues for further investigation and therapy development, enhancing understanding of PDR pathogenesis and aiding targeted intervention creation.
增殖性糖尿病视网膜病变(PDR)是糖尿病的一种严重并发症,了解其分子机制至关重要。内质网(ER)应激与包括糖尿病并发症在内的多种疾病有关。本研究旨在阐明PDR中与ER应激相关的生物标志物,深入了解潜在的分子途径。
我们分析了两个独立的PDR数据集,GSE102485和GSE60436。GSE102485数据集(22个PDR样本和3个正常样本)是进行综合分析的主要数据集,包括差异表达、功能富集、蛋白质-蛋白质相互作用(PPI)网络构建、免疫细胞浸润和药物预测。GSE60436数据集(6个PDR样本和3个正常样本)用于验证。在高糖环境下使用人脐静脉内皮细胞(HUVECs)进行实验,以验证关键的生物信息学结果。蛋白质免疫印迹法评估ER应激标志物(TRAM1和TXNIP)的蛋白质水平。
差异表达分析鉴定出2451个基因,其中包括328个与ER应激相关的基因。功能分析显示在与ER应激相关的过程和途径中富集。鉴定出枢纽基因(BCL2、CCL2、IL-1β、TLR4、TNF、TP53),免疫浸润分析显示免疫细胞比例发生改变。在GSE60436中进行的验证证实了ER应激基因的失调。药物预测提示了靶向ER应激标志物的潜在小分子。
本研究提供了PDR中ER应激的全面分子特征,突出了改变的生物学过程、免疫变化和潜在的治疗靶点。所鉴定的枢纽基因和小分子为进一步研究和治疗开发提供了途径,增进了对PDR发病机制的理解并有助于制定靶向干预措施。